Table 2 The clinicopathological characteristics of CC patients with rapid-engraftment (n = 25) and slow- and non-engraftment (n = 44)
Variable | Rapid-engrafters (n = 25) | Slow- and non- engrafters (n = 44) | p |
|---|---|---|---|
Median age at surgery, years (IQR) | 48 | 54 | 0.345 |
(43–54) | (48–59) | ||
Histology, n (%) | 0.865 | ||
SC | 21 (84.0) | 35 (79.6) | |
AC | 3 (12.0) | 6 (13.6) | |
Others | 1 (4.0) | 3 (6.8) | |
Tumor Stagea, n (%) | 0.057 | ||
Early | 4 (16.0) | 17 (38.6) | |
LACC | 10 (40.0) | 18 (40.9) | |
Advanced | 11 (44.0) | 9 (20.5) | |
Tumor differentiation, n (%) | 0.386 | ||
Poor | 11 (44.0) | 23 (52.3) | |
Moderate | 14 (56.0) | 19 (43.2) | |
Well | 0 (0.0) | 2 (4.5) | |
Tumor Size, n (%) | 0.001 | ||
≥ 4 cm | 10 (40.0) | 36 (81.8) | |
< 4 cm | 15 (60.0) | 8 (18.2) | |
Tumor Invasion, n (%) | 0.449 | ||
Superficial | 9 (36.0) | 12 (27.3) | |
Deep | 16 (64.0) | 32 (72.7) | |
LN metastases, n (%) | 0.009 | ||
Yes | 12 (48.0) | 8 (18.2) | |
No | 13 (52.0) | 36 (81.8) | |
LVSI, n (%) | 0.663 | ||
Yes | 11 (44.0) | 17 (38.6) | |
No | 14 (56.0) | 27 (61.4) | |
SMI, n (%) | 0.846 | ||
Yes | 3 (12.0) | 6 (13.6) | |
No | 22 (88.0) | 38 (86.4) | |
NI, n (%) | 0.433 | ||
Yes | 1 (4.0) | 4 (9.1) | |
No | 24 (96.0) | 40 (90.9) | |
PI, n (%) | 0.097 | ||
Yes | 3 (12.0) | 1 (2.3) | |
No | 22 (88.0) | 43 (97.7) | |
Prognosis, n (%) | 0.17 | ||
Non-recurrence | 20 (80.0) | 37 (84.1) | |
Recurrence | 0 (0) | 1 (2.3) | |
Death | 2 (8.0) | 0 (0.0) | |
Unknown | 3 (12.0) | 6 (13.6) | |